LGnRH-III, lamprey

CAS No. 147859-97-0

LGnRH-III, lamprey( —— )

Catalog No. M30398 CAS No. 147859-97-0

GnRH III, an evolutionarily conserved member of the GnRH family, can stimulate the secretion of gonadotropins, it stimulates the secretion of both luteinizing and follicle-stimulating hormones.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LGnRH-III, lamprey
  • Note
    Research use only, not for human use.
  • Brief Description
    GnRH III, an evolutionarily conserved member of the GnRH family, can stimulate the secretion of gonadotropins, it stimulates the secretion of both luteinizing and follicle-stimulating hormones.
  • Description
    GnRH III, an evolutionarily conserved member of the GnRH family, can stimulate the secretion of gonadotropins, it stimulates the secretion of both luteinizing and follicle-stimulating hormones.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GnRH
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    147859-97-0
  • Formula Weight
    1259.33
  • Molecular Formula
    C59H74N18O14
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 50 mg/mL (39.70 mM)
  • SMILES
    ——
  • Chemical Name
    Sequence:{pGLP}{His}{Trp}{Ser}{His}{Asp}{Trp}{Lys}{Pro}{Gly}-NH2

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Pappa EV, et al. Structure-activity studies of lGnRH-III through rational amino acid substitution and NMR conformational studies. Biopolymers. 2012;98(6):525-34.
molnova catalog
related products
  • Endothelin-2, human

    Endogenous peptide found predominately in the kidney and intestine. Displays similar selectivity for ETA and ETB endothelin receptors.

  • GCN2-IN-1

    GCN2-IN-1 is an effective GCN2 inhibitor and can be used in research on the treatment of cancer as a chemotherapeutic agent.

  • Roemerine

    Roemerine is a potential active xanthine oxidase(XOD) inhibitor, XOD is a key enzyme in the pathogenesis of hyperuricemia and also a well-known target for the drug development to treat gout.